Update on the management of uveitis in children: an overview for the clinician
| Autor: | Sheila T. Angeles-Han, Lucas Kim, Alexa L. Li, Jessica G. Shantha, Steven Yeh |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
genetic structures business.industry Biomedical Engineering Pediatric uveitis food and beverages medicine.disease Article eye diseases 03 medical and health sciences Ophthalmology 0302 clinical medicine 030221 ophthalmology & optometry medicine Intensive care medicine business 030217 neurology & neurosurgery Uveitis Optometry |
| Zdroj: | Expert Rev Ophthalmol |
| ISSN: | 1746-9899 |
| Popis: | INTRODUCTION: Pediatric uveitis comprises a range of ocular inflammatory diseases that may lead to vision impairment, often due to ocular complications from the disease itself or side effects of therapies. The impact on vision, visual functioning, and vision-related quality-of-life over the lifetime horizon can be substantial, underscoring the importance of appropriate ophthalmic evaluation, diagnostic testing and treatment. This review focuses on the anatomic classification, laboratory diagnosis, associated systemic diseases, and management of pediatric uveitis. AREAS COVERED: A review of the literature was performed to synthesize our current understanding of the anatomic classification of pediatric uveitis, disease epidemiology, associated systemic diseases, and management principles. We also review important corticosteroid-sparing strategies including non-biologic and biologic agents such as the anti-tumor necrosis factor (TNF)-alpha family of medications, given their key role in the treatment of pediatric uveitis, particularly juvenile idiopathic arthritis (JIA). Recent advances in the assessment of vision-related quality-of-life using the Effects of Youngsters’ Eyesight on Quality of Life (EYE-Q) instrument are discussed. EXPERT OPINION: Pediatric uveitis can lead to long-term vision impairment if not appropriately screened and treated. JIA is the most common systemic disease associated with uveitis, is typically asymptomatic, and thus requires rigorous screening to detect uveitis and avoid secondary ocular complications. While topical and systemic corticosteroids are useful for the acute treatment of uveitis, the disease chronicity of many pediatric uveitis syndromes including JIA, often warrants early escalation of therapy to immunosuppressive medications including methotrexate (MTX) and anti-TNF-alpha inhibitors. Future directions include an improved understanding of risk factors for uveitis and better metrics to evaluate the impact of disease on vision-related quality-of-life of pediatric uveitis patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|